New inhaler propellant passes first safety check in healthy volunteers
NCT ID NCT06139991
First seen May 12, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study checked if a new propellant (HFO) in a combined budesonide and albuterol inhaler delivers the same amount of medicine into the body as the current version (HFA). 66 healthy adults received single doses of each inhaler type. The goal was to compare drug levels in the blood and ensure the new version is safe and works the same way.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEATHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.